Loading...
Cash Pay Aesthetics Exposure Will Test Injectable Demand Yet Long Term Potential Remains
n/a
n/a
AnalystLowTarget's Fair Value
n/a
1Y
-67.2%7D
-15.7%1Y
-67.2%7D
-15.7%You can edit this narrative until Feb 3 2:10 PM. Then, changes will post as Updates.
Author's Valuation
US$1060.5% undervalued intrinsic discount
AnalystLowTarget Fair Value